You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 801 PRIME™ IL-15 (RPTR-147): Preliminary clinical results and biomarker analysis from a first-in-human Phase 1 study of IL-15 loaded peripherally-derived autologous T cell therapy in solid tumor patients

Citation Tools

Article menu

Download PDFPDF

Late-breaking abstracts
Clinical trials in-progress
801 PRIME™ IL-15 (RPTR-147): Preliminary clinical results and biomarker analysis from a first-in-human Phase 1 study of IL-15 loaded peripherally-derived autologous T cell therapy in solid tumor patients

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Hamilton E, Nikiforow S, Bardwell P, et al
801 PRIME™ IL-15 (RPTR-147): Preliminary clinical results and biomarker analysis from a first-in-human Phase 1 study of IL-15 loaded peripherally-derived autologous T cell therapy in solid tumor patients
Journal for ImmunoTherapy of Cancer 2020;8:doi: 10.1136/jitc-2020-SITC2020.0801